June 16, 2017 10:31 AM EDT

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

Emma Yasinski

→ CFO Paul Clancy left Biogen after 16 years to join Alexion. Under new CEO Ludwig Hantson, Alexion has been undergoing major staffing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus

Emma Yasinski

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

Revolution’s KRAS drugs appear competitive in several lung cancer settings

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Corvus' early-phase atopic dermatitis data prompt stock rally

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Clan­cy joins the new team at Alex­ion, in­vest­ment banker joins Flag­ship, Deeg quick­ly ris­es through ranks at Reg­u­lus

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Clancy joins the new team at Alexion, investment banker joins Flagship, Deeg quickly rises through ranks at Regulus